Cargando…
Prebiotics for Lactose Intolerance: Variability in Galacto-Oligosaccharide Utilization by Intestinal Lactobacillus rhamnosus
Lactose intolerance, characterized by a decrease in host lactase expression, affects approximately 75% of the world population. Galacto-oligosaccharides (GOS) are prebiotics that have been shown to alleviate symptoms of lactose intolerance and to modulate the intestinal microbiota, promoting the gro...
Autores principales: | Arnold, Jason W., Simpson, Joshua B., Roach, Jeffery, Bruno-Barcena, Jose M., Azcarate-Peril, M. Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6213946/ https://www.ncbi.nlm.nih.gov/pubmed/30332787 http://dx.doi.org/10.3390/nu10101517 |
Ejemplares similares
-
The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut
por: Arnold, Jason W., et al.
Publicado: (2021) -
Correction to: The pleiotropic effects of prebiotic galacto-oligosaccharides on the aging gut
por: Arnold, Jason W., et al.
Publicado: (2021) -
Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients
por: Chey, William, et al.
Publicado: (2020) -
Safety and Modulatory Effects of Humanized Galacto-Oligosaccharides on the Gut Microbiome
por: Arnold, Jason W., et al.
Publicado: (2021) -
A double-blind, 377-subject randomized study identifies Ruminococcus, Coprococcus, Christensenella, and Collinsella as long-term potential key players in the modulation of the gut microbiome of lactose intolerant individuals by galacto-oligosaccharides
por: Azcarate-Peril, M. A., et al.
Publicado: (2021)